NeoGenomics Inc.
Organization details
- Legal name
- NeoGenomics Inc.
- Former names
- American Communications Enterprises Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Industrials
- SIC code
- 8734 — Services-Testing Laboratories
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Fort Myers
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NEO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001077183
- EIN
- 74-2897368
- Wikidata ID
- Q48976818
Board of directors
-
Alison L. Hannah · DirectorSince 2023
-
Anthony P. Zook · Director · Chief Executive OfficerSince 2023
-
Bruce K. Crowther · DirectorSince 2023
-
Carolyn S. Starrett · DirectorSince 2026
-
David Brian Perez · DirectorSince 2023
-
Elizabeth Floegel · DirectorSince 2023
-
Felicia Williams · DirectorSince 2024
-
John P. Kenny · DirectorSince 2026
-
Lynn A. Tetrault · DirectorSince 2023
-
Marjorie C. Green · DirectorSince 2025
-
Michael Aaron Kelly · DirectorSince 2023
-
Neil Gunn · DirectorSince 2023
-
Stephen M. Kanovsky · DirectorSince 2023
Chief executives
Director election results
Annual meeting of May 21, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.9%
-
96.9%
-
96.9%
-
97.3%
-
99.1%
-
99.3%
-
99.3%
-
99.4%
-
99.8%
Board connections
6 of this board's directors also sit on 11 other boards.
- via Lynn A. Tetrault
- via John P. Kenny
- via Michael Aaron Kelly
- via Bruce K. Crowther
- via John P. Kenny
- via Felicia Williams
- via Michael Aaron Kelly
- via John P. Kenny
- via Lynn A. Tetrault
- via Alison L. Hannah
- via Bruce K. Crowther
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $967,816
- 5 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 1, 2026 | Stone Warren Officer (Pres & Chief Operating Officer) | Option exercise | +17,562 | — | — |
| Oct 1, 2026 | Stone Warren Officer (Pres & Chief Operating Officer) | Shares withheld for tax | −6,911 | — | — |
| Sep 1, 2026 | Olivo Alicia C Officer (EVP, GC & Business Development) | Shares withheld for tax | −2,692 | — | — |
| Aug 21, 2026 | Stone Warren Officer (Pres & Chief Operating Officer) | Option exercise | +28,106 | — | — |
| Aug 21, 2026 | Stone Warren Officer (Pres & Chief Operating Officer) | Shares withheld for tax | −11,060 | — | — |
| Aug 4, 2026 | Aunan Greg D Officer (Chief Accounting Officer) | Open-market sale | −20,000 | $16.07 | $321,400 |
| Jun 15, 2026 | Lynn A. Tetrault Director | Open-market sale | −5,307 | $11.10 | $58,908 |
| Jun 9, 2026 | Lynn A. Tetrault Director | Open-market sale | −5,307 | $11.29 | $59,916 |
| Jun 1, 2026 | John P. Kenny Director | Option exercise | +5,893 | — | — |
| Jun 1, 2026 | Felicia Williams Director | Option exercise | +23,077 | — | — |
| Jun 1, 2026 | Lynn A. Tetrault Director | Option exercise | +23,077 | — | — |
| Jun 1, 2026 | David Brian Perez Director | Option exercise | +23,077 | — | — |
| Jun 1, 2026 | Michael Aaron Kelly Director | Option exercise | +23,077 | — | — |
| Jun 1, 2026 | Stephen M. Kanovsky Director | Option exercise | +23,077 | — | — |
| Jun 1, 2026 | Neil Gunn Director | Option exercise | +23,077 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about NeoGenomics Inc.
Who is the CEO of NeoGenomics Inc.?
Anthony P. Zook is NeoGenomics Inc.'s Chief Executive Officer.
How many directors are on NeoGenomics Inc.'s board?
NeoGenomics Inc.'s board has 13 directors: Alison L. Hannah, Anthony P. Zook, Bruce K. Crowther, Carolyn S. Starrett, David Brian Perez, Elizabeth Floegel, Felicia Williams, John P. Kenny, Lynn A. Tetrault, Marjorie C. Green and 3 others.
Are NeoGenomics Inc. insiders buying or selling shares?
Over the last 12 months, NeoGenomics Inc. insiders made no open-market purchases and sold $967,816 of shares in 5 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="neogenomics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.